JClinResBioeth

Submit your manuscripts :

[Interventional Cardiology @Interve15538505]

6-year-old. Tet Canal - BTT shunt at age of 2M, then take it down with RVOT opening. Nakata index 120 @OungSavly #Cardiology #trending #Health #Science

[JClinResBioeth @BioethicsJ]

A new study has found that even low levels of exposure to PM2.5, a type of air pollution, can cause liver damage. This is concerning because PM2.

[Interventional Cardiology @Interve15538505]

Best Cases of @SCMRorg 2024 still going! ✅ Hampton Ballroom now ✅ Case 24-04 - Churg-Strauss Syndrome ✅ Will this case win? #SCMR2024 #ChurgStraussSyndrome #Cardiology #MedicalCases @Jason_N_Johnson

[JClinResBioeth @BioethicsJ]

The #WHO guideline on the use of lower-sodium salt substitutes provides evidence-informed guidance for policymakers, program managers, health professionals, and other stakeholders.

[JClinResBioeth @BioethicsJ]

The World Health Organization has certified #Georgia as malaria-free. This marks a significant milestone in the global fight against #malaria. #WHO

[Interventional Cardiology @Interve15538505]

🔹 Horizontal Type 0 Bicuspid—Painful Case! 😓 Any insights? 💭 #BicuspidAorticValve #CardioTwitter #HeartHealth #MedTwitter
@ahakeem143

[JClinResBioeth @BioethicsJ]

which can help identify the best treatment options for patients based on their #genetic profiles.

[JClinResBioeth @BioethicsJ]

#Redcliffe Labs has announced a $10 million investment to expand their genetic and specialized testing portfolio. This investment will allow Redcliffe Labs to offer more advanced and comprehensive testing services, including #pharmacogenomics.

[JClinResBioeth @BioethicsJ]

Eli Lilly's Phase III trial for #donanemab showed successful results in treating Alzheimer's. Donanemab targets amyloid plaque, reducing it by 84% in 18 months compared to 1% with #placebo.

[JClinResBioeth @BioethicsJ]

#CRISPR Trial Success: 2023 saw the first success in a Phase III CRISPR trial, marking a notable achievement in the landscape of clinical trials and paving the way for further advancements in #genetic therapies.

[JClinResBioeth @BioethicsJ]

New #genomics databases are being built to drive major breakthroughs by enabling scientists to compare DNA in unprecedented ways. These databases will facilitate the study of human #genetic diversity, advancing our understanding of various diseases and conditions.

[JClinResBioeth @BioethicsJ]

Researchers have uncovered the specific genes on the Y #chromosome that regulate sperm development and impact male fertility in mice. This research might provide insights into human male #fertility issues.

[JClinResBioeth @BioethicsJ]

Techniques are being developed to map protein localization within tissues and organs, providing a more comprehensive understanding of cellular organization and function. This has significant implications for drug discovery and personalized #medicine.

[JClinResBioeth @BioethicsJ]

Decentralized #Clinical Trials: These trials allow patients to participate from their homes, making them more accessible and potentially increasing diversity among participants.

[JClinResBioeth @BioethicsJ]

Scientists Develop Scans That Light-Up Aggressive Cancer #Tumors for Better Treatment: Scientists have developed new scans that can light up aggressive #cancer tumors, making them easier to see and treat.

[JClinResBioeth @BioethicsJ]

#NanoDrug Delivery System Heralds Safer Era for #Drug Development: A new nano drug delivery system can deliver drugs directly to the site of action, which could lead to safer and more effective treatments.

[JClinResBioeth @BioethicsJ]

#MoonLake Immunotherapeutics initiated 3 new clinical trials for sonelokimab, an investigational #Nanobody® designed to treat inflammatory diseases. The trials are focused on adolescent hidradenitis suppurativa (HS), palmoplantar pustulosis (PPP), axial spondyloarthritis (axSpA).

[JClinResBioeth @BioethicsJ]

#Insilico Medicine announced positive results from Phase I trials of ISM5411, a novel gut-restricted and prolyl hydroxylase domain (PHD)-specific inhibitor designed using AI. The #drug is being considered for the treatment of inflammatory bowel disease (IBD).

[JClinResBioeth @BioethicsJ]

Several clinical trials have faced setbacks, such as the failure of Denali's ALS #drug and Neumora's depression drug. On the other hand, Bayer's menopause drug showed promise in a breast #cancer study.

[JClinResBioeth @BioethicsJ]

Targeted at fundamental processes controlling #skin aging, several therapies are being tested for a potential regulatory-granted anti-aging indication, according to an update in #dermatology.

#antiaging
#clinicalresearch